Terms: = Breast cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
99 results:
1. Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis.
Zheng S; Guo G; Yang Z; Lu Y; Lu K; Fu W; Huang Q
Environ Toxicol; 2024 May; 39(5):2948-2960. PubMed ID: 38308456
[TBL] [Abstract] [Full Text] [Related]
2. A review of nuclear Dbf2-related kinase 1 (ndr1) protein interaction as promising new target for cancer therapy.
Lu J; Feng Y; Yu D; Li H; Li W; Chen H; Chen L
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129188. PubMed ID: 38184050
[TBL] [Abstract] [Full Text] [Related]
3. Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer.
Zhang X; Feng R; Guo J; Pan L; Yao Y; Gao J
BMC Med Genomics; 2023 Nov; 16(1):300. PubMed ID: 37996875
[TBL] [Abstract] [Full Text] [Related]
4. Association between ndrg1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis.
Kotepui K; Kotepui M; Majima HJ; Tangpong J
BMC Cancer; 2023 Oct; 23(1):1003. PubMed ID: 37858101
[TBL] [Abstract] [Full Text] [Related]
5. Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-ndrg1 deregulation.
Mayayo-Peralta I; Debets DO; Prekovic S; Schuurman K; Beerthuijzen S; Almekinders M; Sanders J; Moelans CB; Saleiro S; Wesseling J; van Diest PJ; Henrique R; Jerónimo C; Altelaar M; Zwart W
Mol Oncol; 2024 Jan; 18(1):156-169. PubMed ID: 37854018
[TBL] [Abstract] [Full Text] [Related]
6. Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J; Petrosyan E; Kanojia D; Dmello C; Cordero A; Duffy JT; Yeeravalli R; Sahani MH; Zhang P; Rashidi A; Arrieta VA; Ulasov I; Ahmed AU; Miska J; Balyasnikova IV; James CD; Sonabend AM; Heimberger AB; Lesniak MS
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37847564
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic analyses of genes associated with anoikis in breast cancer.
Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
PeerJ; 2023; 11():e15475. PubMed ID: 37842046
[TBL] [Abstract] [Full Text] [Related]
8. Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.
Ye Y; Luo Y; Guo T; Zhang C; Sun Y; Xu A; Ji L; Ou J; Wu SY
Front Endocrinol (Lausanne); 2023; 14():1179050. PubMed ID: 37600707
[TBL] [Abstract] [Full Text] [Related]
9. Deciphering the mechanisms of action of progesterone in breast cancer.
Chakravorty G; Ahmad S; Godbole MS; Gupta S; Badwe RA; Dutt A
Oncotarget; 2023 Jul; 14():660-667. PubMed ID: 37395734
[TBL] [Abstract] [Full Text] [Related]
10. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
[TBL] [Abstract] [Full Text] [Related]
11. The role of the ndrg1 in the pathogenesis and treatment of breast cancer.
Zhao X; Richardson DR
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188871. PubMed ID: 36841367
[TBL] [Abstract] [Full Text] [Related]
12. Cellular senescence in the response of HR
Klapp V; Buqué A; Bloy N; Sato A; Yamazaki T; Zhou XK; Formenti SC; Galluzzi L; Petroni G
J Transl Med; 2023 Feb; 21(1):110. PubMed ID: 36765430
[TBL] [Abstract] [Full Text] [Related]
13. TGFβ Governs the Pleiotropic Activity of ndrg1 in Triple-Negative breast cancer Progression.
López-Tejada A; Griñán-Lisón C; González-González A; Cara FE; Luque RJ; Rosa-Garrido C; Blaya-Cánovas JL; Navarro-Ocón A; Valenzuela-Torres M; Parra-López M; Calahorra J; Blancas I; Marchal JA; Granados-Principal S
Int J Biol Sci; 2023; 19(1):204-224. PubMed ID: 36594086
[TBL] [Abstract] [Full Text] [Related]
14. Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
La Verde N; Damia G; Garrone O; Santini D; Fabi A; Ciccarese M; Generali DG; Nunzi M; Poletto E; Ferraris E; Cretella E; Scandurra G; Meattini I; Bertolini AS; Cavanna L; Collovà E; Romagnoli E; Rulli E; Legramandi L; Guffanti F; Bramati A; Moretti A; Cassano A; Vici P; Torri V; Farina G;
Breast Cancer Res; 2022 Oct; 24(1):71. PubMed ID: 36307826
[TBL] [Abstract] [Full Text] [Related]
15. ndr1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
[TBL] [Abstract] [Full Text] [Related]
16. Regulatory mechanisms and function of hypoxia-induced long noncoding RNA ndrg1-OT1 in breast cancer cells.
Chao HH; Luo JL; Hsu MH; Chen LH; Lu TP; Tsai MH; Chuang EY; Chuang LL; Lai LC
Cell Death Dis; 2022 Sep; 13(9):807. PubMed ID: 36127332
[TBL] [Abstract] [Full Text] [Related]
17. PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells.
Nguekeu-Zebaze L; Hanini N; Noll A; Wadier N; Amé JC; Roegel L; Dantzer F
Sci Rep; 2022 Sep; 12(1):15534. PubMed ID: 36109561
[TBL] [Abstract] [Full Text] [Related]
18. Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.
Zhao M; Pan B; He Y; Niu B; Gao X
Aging (Albany NY); 2022 Jul; 14(14):5812-5837. PubMed ID: 35859293
[TBL] [Abstract] [Full Text] [Related]
19. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
[TBL] [Abstract] [Full Text] [Related]
20. MAP7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel.
Wang X; Cao X; Wu Y; Chen T
J Chemother; 2023 May; 35(3):231-239. PubMed ID: 35657774
[TBL] [Abstract] [Full Text] [Related]
[Next]
